C
CEL
vs
DD
DD
Over the past 12 months, CEL has underperformed DD, delivering a return of -16% compared to the DD's +40% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
DD
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
C
|
Celadon Pharmaceuticals PLC
LSE:CEL
|
13.4
GBX
|
|||||
|
Dupont De Nemours Inc
NYSE:DD
|
44.4
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
CEL, DD
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
C
|
Celadon Pharmaceuticals PLC
Revenue
|
|||||||||||
|
Dupont De Nemours Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
CEL, DD
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
C
|
Celadon Pharmaceuticals PLC
LSE:CEL
|
|||||||||
|
Dupont De Nemours Inc
NYSE:DD
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Celadon Pharmaceuticals PLC | ||||
|
Dupont De Nemours Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Celadon Pharmaceuticals PLC | ||||
|
Dupont De Nemours Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Celadon Pharmaceuticals PLC | ||||
|
Dupont De Nemours Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Celadon Pharmaceuticals PLC | ||||
|
Dupont De Nemours Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Celadon Pharmaceuticals PLC | ||||
|
Dupont De Nemours Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Celadon Pharmaceuticals PLC | ||||
|
Dupont De Nemours Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Celadon Pharmaceuticals PLC | ||||
|
Dupont De Nemours Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
CEL, DD
Performance Gap
CEL, DD
Performance By Year
CEL, DD
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.